(Q45412292)

14 December 2017

A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy (English)

1 reference

14 December 2017

1 reference

Constantin T Yiannoutsos

2

object named as

Constantin T Yiannoutsos

1 reference

14 December 2017

4

Christina M Marra

1 reference

14 December 2017

1

Giovanni Schifitto

1 reference

14 December 2017

David M Simpson

3

1 reference

14 December 2017

Elyse J Singer

5

1 reference

14 December 2017

Dennis L Kolson

6

1 reference

14 December 2017

Avindra Nath

7

1 reference

14 December 2017

Joseph R Berger

8

1 reference

14 December 2017

Bradford Navia

9

1 reference

14 December 2017

Adult AIDS Clinical Trials Group (ACTG) 301 tEAM

10

1 reference

14 December 2017

1 August 2006

1 reference

14 December 2017

Journal of NeuroVirology

1 reference

14 December 2017

12

1 reference

14 December 2017

4

1 reference

14 December 2017

328-331

1 reference

https://scigraph.springernature.com/pub.10.1080/13550280600873835

14 December 2017

0 references

cites work

NMDA receptors as targets for drug action in neuropathic pain.

1 reference

12 December 2020

Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy

1 reference

12 December 2020

Markers of immune activation and viral load in HIV-associated sensory neuropathy

1 reference

12 December 2020

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

12 December 2020

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

1 reference

12 December 2020

Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain

1 reference

12 December 2020

Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine

1 reference

12 December 2020

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials

1 reference

12 December 2020

Memantine prevents HIV coat protein-induced neuronal injury in vitro

1 reference

12 December 2020

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

1 reference

12 December 2020

Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation

1 reference

12 December 2020

Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain--results of a randomized double-blinded, placebo-controlled trial

1 reference

12 December 2020

Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine

1 reference

12 December 2020

Memantine in moderate-to-severe Alzheimer's disease

1 reference

12 December 2020

Regulation of neural cell survival by HIV-1 infection.

1 reference

12 December 2020

10.1080/13550280600873835

Identifiers

DOI

1 reference

Dimensions Publication ID

14 December 2017

0 references

1 reference